# CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

> **NCT00893516** · PHASE2 · TERMINATED · sponsor: **Emergent BioSolutions** · enrollment: 5 (actual)

## Conditions studied

- T-cell Lymphoma

## Interventions

- **BIOLOGICAL:** CHOP + CD4
- **DRUG:** CHOP

## Key facts

- **NCT ID:** NCT00893516
- **Lead sponsor:** Emergent BioSolutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Portfolio consolidation.
- **Last updated:** 2024-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893516, "CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00893516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*